Market Tracker

07/28 5:24am ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

96.01
Delayed Data
As of Jul 27
 +1.03 / +1.08%
Today’s Change
75.90
Today|||52-Week Range
143.45
-23.70%
Year-to-Date
Nivalis (NVLS): Can the Stock Surprise This Earnings Season?
Jul 27 / Zacks.com - Paid Partner Content
Vertex (VRTX) to Report Q2 Earnings: Is a Surprise in Store?
Jul 25 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure
Jul 27 / Zacks.com - Paid Partner Content
I Just Bought These 4 Fast-Growing Biotech Stocks
Jul 23 / MotleyFool.com - Paid Partner Content
A 'Semi-Charmed' Kind of NXPI Call Spread
Jul 27 / TheStreet.com - Paid Partner Content
Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly
Jul 21 / MotleyFool.com - Paid Partner Content
5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More
Jul 26 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close94.98
Today’s open94.65
Day’s range94.65 - 97.06
Volume2,299,202
Average volume (3 months)1,835,826
Market cap$23.5B
Dividend yield--
Data as of 07/27/2016

Growth & Valuation

Earnings growth (last year)+26.43%
Earnings growth (this year)+191.62%
Earnings growth (next 5 years)+43.00%
Revenue growth (last year)+77.86%
P/E ratioNM
Price/Sales29.41
Price/Book24.89

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+0.45+0.97%
ZTSZoetis Inc-0.07-0.14%
ALXNAlexion Pharmaceutic...+3.13+2.47%
INCYIncyte Corp+1.76+2.02%
Data as of 07/27/2016

Financials

Last reporting dateJuly 25, 2016
EPS forecast (this quarter)$0.21
Annual revenue (last year)$1.0B
Annual profit (last year)-$556.3M
Net profit margin-53.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts